Novartis unit Sandoz AG has filed an appeal after it was was barred from selling a generic version of top-selling blood clot drug Xarelto and […]
Novartis unit Sandoz AG has lost its bid to revoke Bayerâs patents for its top-selling blood clot drug Xarelto and has been barred from selling […]
Sanofi has lost its bid to limit evidence from experts for Amgen in a patent dispute over a cholesterol-lowering antibody, with a judge dismissing concerns […]
German pharmaceutical giant Bayer has slammed generic drug make Sandozâs late bid for documents, which it called an attempt to âdivert and distractâ Bayer on […]
Israeli drug company Neurim Pharmaceuticals has lost a bid to patent a mini version of its melatonin tablet Circadin for children, after a successful challenge […]
The High Court will not wade into the global debate over whether artificial intelligence inventions should receive patent protection, letting stand a Full Court judgment […]
French drug giant Sanofi has appealed a decision giving American biopharmaceutical company Amgen the go-ahead for its patents for a cholesterol-lowering antibody that could be […]
Gaming giant Aristocrat Technologies has lost its legal challenge to a decision that rejected a patent for its popular Lightning Link electronic poker machine, after […]
Bristol-Myers Squibb unit Celgene and two generic drug makers have withdrawn an application for ACCC approval of a patent settlement that would have allowed for […]
The High Court has been asked to wade into the debate over whether artificial intelligence can be named as an inventor on patent applications, after […]